Positron emission tomography at the end of first-line therapy and during follow-up in patients with Hodgkin lymphoma: a retrospective study von Mocikova, H., Obrtlikova, P., Vackova, B., Trneny, M.

Volltext

Advances in the treatment of chronic lymphocytic leukaemia von Obrtlíková, P, Trněný, M

Volltext

Monoclonal Antibodies in the Treatment of Chronic Lymphocytic Leukemia in 2015 von Obrtlíková, P, Urbanová, R

Volltext

Pokroky v onkohematologii v 21. století von Neuwirtová, R, Klamová, H, Špička, I, Benešová, K, Obrtlíková, P, Jonášová, A

Volltext

MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia von Vargova, K, Pesta, M, Obrtlikova, P, Dusilkova, N, Minarik, L, Vargova, J, Berkova, A, Zemanova, Z, Michalova, K, Spacek, M, Trneny, M, Stopka, T

Volltext

Monoclonal Antibodies in the Treatment of Chronic Lymphocytic Leukemia in 2015 von Obrtlíková, P, Urbanová, R

Volltext

P-202 MDS development risk in CLL patients with prolonged cytopenia after fludarabine, cyclophosphamide and rituximab (FCR) régime von Jonasova, A, Obrtlikova, P, Siskova, M, Cmunt, E, Berkova, A, Karban, J, Svackova, K, Trneny, M

Volltext

Dendritic cells and T lymphocyte interactions in patients with lymphoid malignancies von Pytlík, R, Hofman, P, Kideryová, L, Červinková, P, Obrtlíková, P, Šálková, J, Trněný, M, Klener, P

Volltext

Guidelines for alemtuzumab treatment in chronic lymphocytic leukaemia (CLL) von Smolej, L, Procházka, V, Špaček, M, Obrtlíková, P, Gumulec, J, Vokurka, S, Doubek, M

Volltext

Not Available von Neuwirtová, R, Klamová, H, Špička, I, Benešová, K, Obrtlíková, P, Jonášová, A

Volltext

Nonhuman primate embryonic stem cells as a preclinical model for hematopoietic and vascular repair von Hematti, Peiman, Obrtlikova, Petra, Kaufman, Dan S.

Volltext

Correlation of lymphocyte recovery and progression-free survival after autologous stem cell transplantation in patients with Hodgkin's lymphoma von Mocikova, H, Vackova, B, Pytlik, R, Obrtlikova, P, Kobylka, P, Trneny, M

Volltext

Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia von Moreno, Carol, Montillo, Marco, Panayiotidis, Panayiotis, Dimou, Maria, Bloor, Adrian, Dupuis, Jehan, Schuh, Anna, Norin, Stefan, Geisler, Christian, Hillmen, Peter, Doubek, Michael, Trněný, Marek, Obrtlikova, Petra, Laurenti, Luca, Stilgenbauer, Stephan, Smolej, Lukas, Ghia, Paolo, Cymbalista, Florence, Jaeger, Ulrich, Stamatopoulos, Kostas, Stavroyianni, Niki, Carrington, Patrick, Zouabi, Hamadi, Leblond, Veronique, Gomez-Garcia, Juan C, Rubio, Martin, Marasca, Roberto, Musuraca, Gerardo, Rigacci, Luigi, Farina, Lucia, Paolini, Rossella, Pospisilova, Sarka, Kimby, Eva, Bradley, Colm, Montserrat, Emili

Volltext